Injury risk; stem-cell start; food faces
People with autism are at high risk of death from injury, China starts a clinical trial involving human embryonic stem cells, and individuals with autism have trouble seeing faces in food.
People with autism are at high risk of death from injury, China starts a clinical trial involving human embryonic stem cells, and individuals with autism have trouble seeing faces in food.
Proposed cuts to biomedical research in the United States spark outrage, the autism research community has lost a legend in Isabelle Rapin, and scientists like to move around.
Negative experiences, such as being bullied or socially isolated, may lead to hallucinations.
More than 40 percent of children with Phelan-McDermid syndrome lose skills they once had, beginning, on average, at age 6.
The National Institutes of Health receives a $2 billion boost, politicians who propagate anti-vaccine views are fueling outbreaks, and a new report highlights preventable conditions associated with autism.
Scott Gottlieb is poised to become chief of the U.S. Food and Drug Administration, neuroscience research has blossomed over the past decade, and new grants support adults with autism.
A drug used to treat excessive swelling seems to ease autism features in some children on the spectrum.
Using flashes of light, scientists can spark seizures, tweak cell junctions and motivate mice from afar.
The Broad Institute can keep its CRISPR patents, Trump’s vaccine safety panel may be back on, and a drug discovered in fish eases seizures in children.
Some mutations in a gene called SCN2A make neurons less excitable and are linked to autism; others have the opposite effect and may cause seizures during infancy.